Quantcast

Latest Diabetes mellitus type 1 Stories

2014-06-12 08:29:14

RALEIGH, N.C., June 12, 2014 /PRNewswire/ -- Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing novel technologies for the treatment and diagnosis of metabolic disease, announced today it will present three peer-reviewed posters relating to its differentiated sodium glucose transporter 2 (SGLT2) inhibitor, remogliflozin etabonate, at the 74(th) American Diabetes Association (ADA) Scientific Sessions at the Moscone Center in San Francisco, June 13-17. Two of...

2014-06-11 23:07:57

Allegheny Health Network today announced that Massimo Trucco, MD, one of the world’s foremost physician-scientists with expertise in diabetes and immunogenetics, has been recruited to lead a newly established Institute of Cellular Therapeutics based at Allegheny General Hospital (AGH). Pittsburgh, PA (PRWEB) June 11, 2014 Allegheny Health Network today announced that Massimo Trucco, MD, one of the world’s foremost physician-scientists with expertise in diabetes and immunogenetics, has...

2014-06-10 20:21:55

Broad Institute researchers and collaborators harness whole-exome sequencing in study of 4,000 Latin Americans; reveal gene variant of strong effect that might guide treatment CAMBRIDGE, Mass. and MEXICO CITY, June 10, 2014 /PRNewswire/ -- In the largest study of its kind published to date, an international team of researchers in Mexico and the United States has discovered a strong genetic risk factor for type 2 diabetes that primarily affects Latin American patients, but is rare elsewhere....

2014-06-10 16:30:54

Follow the discussion on Twitter at #DOCatADA SAN FRANCISCO, June 10, 2014 /PRNewswire-iReach/ -- Korey Hood, PhD and a select group of patient advocates from the Diabetes Online Community (DOC) will deliver a trailblazing session on the benefits of engaging with the Diabetes Online Community for both clinicians and patients at this year's American Diabetes Association 74(th) Scientific Sessions. Entitled The Art and Science of Behavioral Medicine Principles in the Diabetes Online...

2014-06-10 08:30:52

Phase 3 Study Results Across Different Patient Populations, Including Comparative Analyses with Sitagliptin and Health Economics Data, are Among 15 Accepted Presentations RARITAN, N.J., June 10, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that 15 presentations on INVOKANA(®) (canagliflozin) will be made at the American Diabetes Association (ADA) 74(th) Scientific Sessions(®), June 13-17 in San Francisco. The presentations include long-term safety...

2014-06-09 08:30:07

Company to highlight late-stage pipeline molecules, including once-weekly dulaglutide and basal insulin peglispro INDIANAPOLIS, June 9, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced 76 abstracts to be presented June 13-17 at the 74(th) American Diabetes Association Scientific Sessions(®) in San Francisco, highlighting the company's long-standing commitment to advancing scientific knowledge in the field of diabetes management. Forty-three of these abstracts will be...

2014-06-09 08:29:08

VANCOUVER, June 9, 2014 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF) today announced top-line results related to the eight month visual acuity (VA) primary endpoint for subjects enrolled in the Phase 2 iDEAL Study, conducted in collaboration with JDRF, evaluating the efficacy and safety after repeated injections of iCo-007 in patients with Diabetic Macular Edema (DME). Statistical methods employed included both Last Observation Carry...

2014-06-09 08:25:24

Driver joins 10-year camp vet Kris Freeman to help inspire children with type 1 diabetes nationwide INDIANAPOLIS, June 9, 2014 /PRNewswire/ -- News Highlights: -- #Lilly #Diabetes boosts Camp Care Package speaker program adding 20-yr-old NASCAR @driverRyanReed; cheers 10 yrs with skier Kris Freeman When NASCAR Nationwide Series (NNS) driver Ryan Reed set out to plan his summer, canoeing and archery may not have been on his to-do list...but they are now. Today, Lilly Diabetes...

2014-06-07 23:03:48

RnRMarketResearch.com adds “Blood Glucose Testing and Diabetes Management” to its store. Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=58685. Dallas, Texas (PRWEB) June 07, 2014 There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease, sometimes referred to as juvenile diabetes, now mostly Type...

2014-06-04 08:29:58

MISSISSAUGA, ON, June 4, 2014 /CNW/ - Novo Nordisk today announces that the Québec government has approved the inclusion of Victoza(®) (liraglutide), the first once-daily human glucagon-like peptide-1 (GLP-1) analogue, to the Lists of Medications, effective June 2, 2014. The reimbursement of Victoza(®) by the Québec Health Insurance Board (RAMQ) will allow people living with type 2 diabetes to have access to a treatment to help better manage diabetes. Québec is the first...


Latest Diabetes mellitus type 1 Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

More Articles (1 articles) »
Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related